Jennifer C. Price’s Standard BioTools LAB Stock Holding History

Jennifer C. Price’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.41M	Sell	803,282 -90,000	-10%	-$168K	1.86%	12
2024 Q3	$1.72M	Sell	893,282 -86,818	-9%	-$170K	1.92%	14
2024 Q2	$1.73M	Hold	980,100	–	–	2.02%	18
2024 Q1	$2.66M	Hold	980,100	–	–	2.51%	13
2023 Q4	$2.17M	Hold	980,100	–	–	1.44%	23
2023 Q3	$2.84M	Hold	980,100	–	–	1.64%	22
2023 Q2	$1.89M	Buy	980,100 +7,346	+0.8%	+$14.5K	0.65%	43
2023 Q1	$1.9M	Hold	972,754	–	–	0.6%	44
2022 Q4	$1.14M	Buy	972,754 +118,554	+14%	+$146K	0.27%	54
2022 Q3	$940K	Buy	854,200 +609,200	+249%	+$921K	0.19%	67
2022 Q2	$392K	Buy	+245,000	New	+$606K	0.07%	84

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Jennifer C. Price's LAB Position: Q4 2024 in Review

Jennifer C. Price reduced its Standard BioTools (LAB) stake by 10% in Q4 2024, selling an estimated $168K and leaving 803,282 shares worth $1.41M. The position accounts for 1.86% of the portfolio, ranked #12.

Jennifer C. Price first reported a position in LAB in Q2 2022 and has held it in 11 quarters since. The position peaked at $2.84M in Q3 2023. 142 funds tracked by Wall St. Rank hold LAB as of Q4 2024.

Jennifer C. Price held 803,282 shares of Standard BioTools worth $1.41M as of Q4 2024.
Jennifer C. Price sold 90,000 Standard BioTools shares in Q4 2024, an estimated $168K.
Standard BioTools made up 1.86% of Jennifer C. Price's portfolio in Q4 2024, its #12 holding.
Jennifer C. Price first reported a position in Standard BioTools in Q2 2022 and has held it in 11 quarters since.
Jennifer C. Price's Standard BioTools position peaked at $2.84M in Q3 2023.
142 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2024.

Based on Jennifer C. Price's 13F filing for Q4 2024, filed 13 Feb 2025.